Get started
Author

Joelle Lufkin

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
2013 · Steven J. O'Day, Alexander M.M. Eggermont, et al. · Journal of Clinical Oncology · 385
PDF
Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain
2018 · Philip G. Conaghan, David J. Hunter, et al. · Journal of Bone and Joint Surgery · 187
PDF
Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)
2017 · V.B. Kraus, P.G. Conaghan, et al. · Osteoarthritis and Cartilage · 156
PDF
An Intra-Articular, Extended-Release Formulation of Triamcinolone Acetonide Prolongs and Amplifies Analgesic Effect in Patients with Osteoarthritis of the Knee
2015 · Neil Bodick, Joelle Lufkin, et al. · Journal of Bone and Joint Surgery · 135
Brief Report: A Phase II b Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis
2017 · Philip G. Conaghan, Stanley B. Cohen, et al. · Arthritis & Rheumatology · 98
PDF
Brief Report: A phase IIa, randomized, double‐blind, placebo‐controlled trial of apilimod mesylate, an interleukin‐12/interleukin‐23 inhibitor, in patients with rheumatoid arthritis
2011 · Sarah Krausz, Maria J. H. Boumans, et al. · Arthritis & Rheumatism · 89
An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).
2011 · K. Wong, M. Koczywas, et al. · Journal of Clinical Oncology · 62
Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study
2018 · Steven J Russell, Robert Sala, et al. · Rheumatology · 44
PDF
Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis
2019 · Michael J. Langworthy, Philip G. Conaghan, et al. · Advances in Therapy · 39
PDF
Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study
2019 · Andrew I. Spitzer, John C. Richmond, et al. · Rheumatology and Therapy · 39
PDF
Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials
2019 · Alan J. Kivitz, Philip G. Conaghan, et al. · Pain and Therapy · 18
PDF
FX006 prolongs the residency of triamcinolone acetonide in the synovial tissues of patients with knee osteoarthritis
2013 · N. Bodick, J. Lufkin, et al. · Osteoarthritis and Cartilage · 17
PDF
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study
2021 · Peter Hanson, Alan Kivitz, et al. · Drugs in R&D · 13
PDF
A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis
2019 · Alan Kivitz, Louis Kwong, et al. · Therapeutic Advances in Musculoskeletal Disease · 12
A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis
2022 · Alan Kivitz, Purvi Mehra, et al. · Rheumatology and Therapy · 8
PDF
Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales
2021 · Edgar Ross, Nathaniel P. Katz, et al. · Pain and Therapy · 8
PDF
1033P First-in-human study of MALT1 inhibitor MPT-0118: Results from monotherapy dose escalation in advanced or metastatic refractory solid tumors
2023 · A. Naing, J.C. Park, et al. · Annals of Oncology · 6
PDF
Synovial and systemic pharmacokinetics of triamcinolone acetonide following intra-articular injection of an extended release formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis
2017 · V. Byers-Kraus, H.A. Aazami, et al. · Osteoarthritis and Cartilage · 6
PDF
An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials
2017 · P. Conaghan, V. Strand, et al. · Osteoarthritis and Cartilage · 5
Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study
2016 · P.G. Conaghan, S. Cohen, et al. · Osteoarthritis and Cartilage · 4
Prolonged joint residency of triamcinolone acetonide after an intra-articular injection of FX006, a sustained release formulation for the treatment of osteoarthritis
2015 · N. Bodick, J. Lufkin, et al. · Osteoarthritis and Cartilage · 4
PDF
Triamcinolone acetonide extended-release injectable suspension (TA-ER) is associated with reduced blood glucose elevation vs. standard triamcinolone in type 2 diabetes mellitus patients with knee osteoarthritis: a randomized, blinded, parallel-group study
2018 · P.G. Conaghan, S.J. Russell, et al. · Osteoarthritis and Cartilage · 3
PDF
Benefits and Safety of Long-Term Use of IMR-687 As Monotherapy or in Combination with a Stable Dose of Hydroxyurea (HU) in 2 Adult Sickle Cell Patients
2020 · Lanetta Bronte-Hall, Biree Andemariam, et al. · Blood · 2
Safety and efficacy of FX006 in patients with osteoarthritis of the knee
2014 · N. Bodick, J. Lufkin, et al. · Osteoarthritis and Cartilage · 2
1230 POSTER A Phase 1 and Pharmacokinetic Study of Ganetespib (STA-9090), a Heat Shock Protein 90 Inhibitor, in Combination With Docetaxel in Subjects With Advanced Solid Tumour Malignancies
2011 · R.D. Harvey, C.M. Lewis, et al. · European Journal of Cancer · 2
Works count: 36
Citation count: 1,345
H-index: 13
I10-index: 14
Year
Topic
Type